Related Links Educational Materials About Clinical Trials Clinical Trials Questions to Ask Your Doctor Drug Information from MedlinePlus

Alternate Title
Basic Trial Information
Trial Description
     Purpose
     Eligibility
     Treatment/Intervention
Trial Contact Information
Registry Information

Alternate Title

Compassionate Use of Oral Beclomethasone in Patients With Gastrointestinal Graft-Versus-Host Disease

Basic Trial Information

Phase	Type	Status	Age	Sponsor	Protocol IDs
No phase specified	Supportive care	Closed	4 to 70	NCI	RPCI-DS-01-04 NCT00055666

Trial Description

Purpose:

Beclomethasone may be effective in treating patients who have graft-versus-host disease of the gastrointestinal tract.

Compassionate use of beclomethasone in treating patients who have graft-versus-host disease of the gastrointestinal tract that has not responded to previous therapy.

Eligibility:

Eligibility criteria include the following:

• 4-70 years old
• For more information about the eligibility criteria for this trial, refer to the Health Professional version.

Final eligibility for a clinical trial is determined by the health professionals conducting the trial.

Treatment/Intervention:

Patients will receive beclomethasone by mouth four times a day for 4 weeks. One or two courses of treatment may be repeated up to four times a year.

Important:

For more details about this trial, refer to the Health Professional version of the trial summary.

If you are interested in participating in a clinical trial, contact your doctor for a referral or call a trial contact person listed below. You may see the same contact person listed at more than one site, however, if you call the number listed you can ask to speak to the study coordinator or person involved with the specific trial you are interested in. If you have questions about cancer or clinical trials, call the Cancer Information Service at 1-800-4-CANCER (1-800-422-6237). General information about clinical trials, including risks, benefits, and costs, can be found on NCI's Web site.

Trial Contact Information

Trial Lead Organizations

Roswell Park Cancer Institute

Philip McCarthy, MD, Protocol chair		Ph: 716-845-4074; 800-685-6825 Email: philip.mccarthy@roswellpark.org

Registry Information
Official Title		Compassionate Use Of Oral Beclomethasone Dipropionate For Treatment Of Gastrointestinal Graft Versus Host Disease
Trial Start Date		2001-03-27
Registered in ClinicalTrials.gov		NCT00055666
Date Submitted to PDQ		2003-01-07
Information Last Verified		2005-09-08
NCI Grant/Contract Number		CA16056

Back to Top